Abstract
Purpose of review
Our purpose is to discuss the importance of multimodality imaging in the assessment of cardiac tumors and management. We have compiled a recent review of the scientific literature and embedded our clinical pathways and recommendations based on data and clinical experience.
Recent findings
The use of contrast echocardiography in the assessment of cardiac masses has been shown to be helpful in distinguishing tumor from thrombus. Deformation imaging of cardiac tumors has been shown to differentiate better rhabdomyomas from fibromas in pediatric patients. Cardiac MRI (CMR) appears to be helpful in determining whether cardiac tumors are benign or malignant by identifying presence of infiltration, uptake of contrast in first pass perfusion and gadolinium enhancement. Patients with evidence of cardiac metastases by CMR show similar survival to stage IV cancer without cardiac metastases. In our institution, we use a standardized approach for the evaluation of cardiac masses, which includes multimodality imaging in the appropriate clinical context. The autotransplantation surgical technique has shown some promise in improving survival in patients with primary cardiac sarcomas. In our institution, we do not routinely recommend anticoagulation for “tumor-thrombus” in renal cell carcinoma due to risk of bleeding from primary tumor.
Summary
Cardiac masses are often found incidentally, but sometimes can present with cardiovascular symptoms due to obstruction and valvular dysfunction, which may prompt imaging. It is important to determine whether the mass is a normal variant, imaging artifact, vegetation, thrombus, or tumor. Transthoracic echocardiography is ideally suited to be the initial imaging modality because of the portability, wide availability, lack of radiation, and relatively low cost. The gold standard cardiac imaging technique to distinguish tumor from thrombus is contrast enhanced CMR with prolonged inversion time. Advantages of CMR when compared to echocardiography regarding characterization of cardiac tumors are as follows: larger field of view, better spatial resolution, better tissue characterization, lack of attenuation, and ability to image at any prescribed plane. Primary and secondary cardiac tumors have particular characteristics in echocardiography and CMR. Imaging of cardiac tumors plays an important role in establishing a diagnosis and in planning management.
Similar content being viewed by others
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
• Hudzik B, et al. Malignant tumors of the heart. Cancer Epidemiol. 2015;39(5):665–72. Updated review on malignant tumors of the heart, a good reference
Butany J, et al. Cardiac tumours: diagnosis and management. Lancet Oncol. 2005;6(4):219–28.
•• Bertrand PB, et al. Fact or artifact in two-dimensional echocardiography: avoiding misdiagnosis and missed diagnosis. J Am Soc Echocardiogr. 2016;29(5):381–91. Thorough review on artifacts in echocardiography commonly seen in clinical practice
Le HT, et al. Imaging Artifacts in Echocardiography. Anesth Analg. 2016;122(3):633–46.
Alam M. Pitfalls in the echocardiographic diagnosis of intracardiac and extracardiac masses. Echocardiography. 1993;10(2):181–91.
Martin RP, et al. Clinical utility of two dimensional echocardiography in infective endocarditis. Am J Cardiol. 1980;46(3):379–85.
Kamran H, et al. Lambl’s excrescences: a case report and review of the literature. Clin Case Rep Rev. 2016;2(7):486–8.
Jaffe W, Figueredo VM. An example of Lambl’s excrescences by transesophageal echocardiogram: a commonly misinterpreted lesion. Echocardiography. 2007;24(10):1086–9.
Tower-Rader A, Kwon D. Pericardial masses, cysts and diverticula: a comprehensive review using multimodality imaging. Prog Cardiovasc Dis. 2017;59(4):389–97.
Roberts WC. Primary and secondary neoplasms of the heart. Am J Cardiol. 1997;80(5):671–82.
Tao TY, et al. Pediatric cardiac tumors: clinical and imaging features. Radiographics. 2014;34(4):1031–46.
Shapiro LM. Cardiac tumours: diagnosis and management. Heart. 2001;85(2):218–22.
Gowda RM, et al. Cardiac papillary fibroelastoma: a comprehensive analysis of 725 cases. Am Heart J. 2003;146(3):404–10.
Bass JL, Breningstall GN, Swaiman KF. Echocardiographic incidence of cardiac rhabdomyoma in tuberous sclerosis. Am J Cardiol. 1985;55(11):1379–82.
King SJ, Smallhorn JF, Burrows PE. Epicardial lipoma: imaging findings. AJR Am J Roentgenol. 1993;160(2):261–2.
Mullen JC, et al. Right atrial lipoma. Ann Thorac Surg. 1995;59(5):1239–41.
Osranek M, et al. Echocardiographic features of pheochromocytoma of the heart. Am J Cardiol. 2003;91(5):640–3.
Araoz PA, et al. CT and MR imaging of benign primary cardiac neoplasms with echocardiographic correlation. Radiographics. 2000;20(5):1303–19.
Burke A, Johns JP, Virmani R. Hemangiomas of the heart. A clinicopathologic study of ten cases. Am J Cardiovasc Pathol. 1990;3(4):283–90.
Kojima S, et al. Cardiac hemangioma: a report of two cases and review of the literature. Heart Vessel. 2003;18(3):153–6.
Kupsky DF, et al. Echocardiographic features of cardiac angiosarcomas: the Mayo Clinic experience (1976–2013). Echocardiography. 2016;33(2):186–92.
Tighe DA, et al. Primary cardiac lymphoma. Echocardiography. 2000;17(4):345–7.
Kurosawa T, et al. Primary malignant pericardial mesothelioma with increased serum mesothelin diagnosed by surgical pericardial resection: a case report. Mol Clin Oncol. 2016;5(5):553–6.
Istomin V, et al. Pericardial effusion due to primary malignant pericardial mesothelioma: a common finding but an uncommon cause. Case Rep Med. 2016;2016:4810901.
Barroso AS, et al. Pericardial mesothelioma presenting as a suspected ST-elevation myocardial infarction. Rev Port Cardiol. 2017;36(4):307.e1–5.
Salcedo EE, et al. Cardiac tumors: diagnosis and management. Curr Probl Cardiol. 1992;17(2):73–137.
Wood A, et al. Metastatic malignant melanoma manifesting as an intracardiac mass. Cardiovasc Pathol. 2010;19(3):153–7.
Abdelmoneim SS, et al. Assessment of the vascularity of a left atrial mass using myocardial perfusion contrast echocardiography. Echocardiography. 2008;25(5):517–20.
Kirkpatrick JN, et al. Differential diagnosis of cardiac masses using contrast echocardiographic perfusion imaging. J Am Coll Cardiol. 2004;43(8):1412–9.
Ganame J, D’Hooge J, Mertens L. Different deformation patterns in intracardiac tumors. Eur J Echocardiogr. 2005;6(6):461–4.
Hendel RC, et al. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol. 2006;48(7):1475–97.
Beroukhim RS, et al. Characterization of cardiac tumors in children by cardiovascular magnetic resonance imaging: a multicenter experience. J Am Coll Cardiol. 2011;58(10):1044–54.
Weinsaft JW, et al. LV thrombus detection by routine echocardiography: insights into performance characteristics using delayed enhancement CMR. JACC Cardiovasc Imaging. 2011;4(7):702–12.
Abbas A, et al. Cardiac MR assessment of cardiac myxomas. Br J Radiol. 2015;88(1045):20140599.
Colin GC, et al. Cardiac myxoma imaging features and tissue characteristics at cardiovascular magnetic resonance. Int J Cardiol. 2016;202:950–1.
Rahsepar AA, et al. A papillary fibroelastoma involving aortic and pulmonary valves: findings on multimodality imaging. Ann Thorac Surg. 2017;103(1):e73–5.
•• Pazos-Lopez P, et al. Value of CMR for the differential diagnosis of cardiac masses. JACC Cardiovasc Imaging. 2014;7(9):896–905. Very important study that validates the usefulness of CMR in the evaluation of cardiac masses. Describes the features of malignant and benign tumors in CMR
• Lopez-Mattei J, et al. The role of cardiac MRI in cardio-oncology. Futur Cardiol. 2017;13(4):311–6. This review from our center illustrates the role of CMR in our practice
Kim MP, et al. Outcomes after right-side heart sarcoma resection. Ann Thorac Surg. 2011;91(3):770–6.
•• Pun, S.C., et al.. Pattern and prognostic implications of cardiac metastases among patients with advanced systemic cancer assessed with cardiac magnetic resonance imaging. J Am Heart Assoc. 2016. 5(5). Important study that emphasize the role of CMR in diagnosing metastatic disease and its relation with staging cancer patients in certain clinical scenarios.
• Lopez-Mattei, J. Chapter 9. Evaluation of a Cardiac Mass, in MD Anderson Practices in Onco-cardiology, Editor: Edward T.H. Yeh, M.D., F.A.C.C. 2016. p 29–30. This is a summary of our standardized approach of cardiac masses evaluation.
Zatorska K, et al. The usefulness of magnetic resonance imaging in the diagnosis of infectious endocarditis. J Heart Valve Dis. 2015;24(6):767–75.
Reynen K. Cardiac myxomas. N Engl J Med. 1995;333(24):1610–7.
Colucci WS, Schoen FJ, Braunwald E. Primary tumors of the heart. In: Braunwald E, editor. Heart disease: a textbook of cardiovascular medicine. Philadelphia: W.B. Saunders Company; 1997. p. 1464–77.
Blackmon SH, Reardon MJ. Cardiac neoplasms. In: Cohn LH, editor. Cardiac surgery in the adult. New York: McGraw-Hill Medical; 2012.
Ngaage DL, et al. Surgical treatment of cardiac papillary fibroelastoma: a single center experience with eighty-eight patients. Ann Thorac Surg. 2005;80(5):1712–8.
Sun JP, et al. Clinical and echocardiographic characteristics of papillary fibroelastomas: a retrospective and prospective study in 162 patients. Circulation. 2001;103(22):2687–93.
Nir A, et al. Tuberous sclerosis and cardiac rhabdomyoma. Am J Cardiol. 1995;76(5):419–21.
Bossert T, et al. Cardiac fibroma as an inherited manifestation of nevoid basal-cell carcinoma syndrome. Tex Heart Inst J. 2006;33(1):88–90.
Neragi-Miandoab S, Kim J, Vlahakes GJ. Malignant tumours of the heart: a review of tumour type, diagnosis and therapy. Clin Oncol (R Coll Radiol). 2007;19(10):748–56.
Cohen RA, et al. Mature cardiac teratoma in an adult. Cardiol Res. 2012;3(3):97–9.
Balasundaram S, Halees SA, Duran C. Mesothelioma of the atrioventricular node: first successful follow-up after excision. Eur Heart J. 1992;13(5):718–9.
Bruckner BA, Reardon MJ. Benign cardiac tumors: a review. Methodist Debakey Cardiovasc J. 2010;6(3):20–6.
Lee KJ, et al. A case of arteriovenous type cardiac hemangioma. Korean J Intern Med. 1998;13(2):123–6.
Song JY, et al. Silent left ventricular hemangioma. Acta Cardiologica Sinica. 2013;29(6):562–4.
Simpson L, et al. Malignant primary cardiac tumors: review of a single institution experience. Cancer. 2008;112(11):2440–6.
Reardon MJ. Malignant tumor overview. Methodist Debakey Cardiovasc J. 2010;6(3):35–7.
Reardon MJ, Walkes JC, Benjamin R. Therapy insight: malignant primary cardiac tumors. Nat Clin Pract Cardiovasc Med. 2006;3(10):548–53.
Vaporciyan A, Reardon MJ. Right heart sarcomas. Methodist Debakey Cardiovasc J. 2010;6(3):44–8.
Ravi V, Benjamin RS. Systemic therapy for cardiac sarcomas. Methodist Debakey Cardiovasc J. 2010;6(3):57–60.
Leja MJ, et al. Metastatic melanoma to the intracavitary left ventricle treated using cardiac autotransplantation technique for resection. Methodist Debakey Cardiovasc J. 2011;7(4):44–6.
Rice DC, Reardon MJ. Left heart sarcomas. Methodist Debakey Cardiovasc J. 2010;6(3):49–56.
Blackmon SH, Reardon MJ. Pulmonary artery sarcoma. Methodist Debakey Cardiovasc J. 2010;6(3):38–43.
Yusuf SW, et al. Cardiac tumors in a tertiary care cancer hospital: clinical features, echocardiographic findings, treatment and outcomes. Heart Int. 2012;7(1):e4.
Ceresoli GL, et al. Primary cardiac lymphoma in immunocompetent patients: diagnostic and therapeutic management. Cancer. 1997;80(8):1497–506.
Petrich A, Cho SI, Billett H. Primary cardiac lymphoma: an analysis of presentation, treatment, and outcome patterns. Cancer. 2011;117(3):581–9.
Bambury R, et al. Primary cardiac lymphoma: diagnostic tools and treatment challenges. Ir J Med Sci. 2011;180(1):271–3.
Woodruff DY, et al. The perioperative management of an inferior vena caval tumor thrombus in patients with renal cell carcinoma. Urol Oncol. 2013;31(5):517–21.
Nesbitt JC, et al. Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus. Ann Thorac Surg. 1997;63(6):1592–600.
Wood, C.G., Anticoagulation for renal IVC tumor thrombus, Thompson KA, editor. 2013.
Reardon MJ. Cardiac tumor issue overview. Methodist Debakey Cardiovasc J. 2010;6(3):2–3.
Leja MJ, Shah DJ, Reardon MJ. Primary cardiac tumors. Tex Heart Inst J. 2011;38(3):261–2.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Nicolas Palaskas, Kara Thompson, Ali M. Agha, Saamir Hassan, Cezar Iliescu, Peter Kim, Jean B. Durand, and Juan C. Lopez-Mattei each declare no potential conflicts of interest. Gregory Gladish reports speaker honoraria from Bristol Myers Squibb.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Cardio-oncology
Rights and permissions
About this article
Cite this article
Palaskas, N., Thompson, K., Gladish, G. et al. Evaluation and Management of Cardiac Tumors. Curr Treat Options Cardio Med 20, 29 (2018). https://doi.org/10.1007/s11936-018-0625-z
Published:
DOI: https://doi.org/10.1007/s11936-018-0625-z